Home About us Contact
|
Home About us Contact | ||
|
|
||
Subsequent Reduction (subsequent + reduction)
Selected AbstractsSynthetic, Structural, and Electrochemical Studies of 2-Ferrocenyl- and2-Cymantrenyl-Functionalized 2,3-Dihydro-1H -1,3,2-diazaboroles and1,3,2-DiazaborolidenesEUROPEAN JOURNAL OF INORGANIC CHEMISTRY, Issue 23 2005Lothar Weber Abstract Reaction of (dibromoboryl)ferrocene (1) with 1 equiv. of the diazabutadiene tBuN=CH,CH=NtBu, and subsequent reduction of the obtained borolium salt 2 with sodium amalgam, affords the first ferrocenyl-functionalized 1,3,2-diazaborole (3). Similarly, 1,1,-bis(dibromoboryl)ferrocene (4) can be transformed into compound 6, which contains two diazaborolyl substituents at the ferrocene core. Treatment of precursors 1 and 4 with 1,2-bis(tert -butylamino)ethane in the presence of Et3N gives rise to the formation of the diazaborolidine derivatives 13 and 14. 1-Dibromoboryl-3-methylcymantrene (7) was also treated with tBuN=CH,CH=NtBu to give the borolium salt 8, which was subsequently reduced to the 2-cymantrenyl-diazaborole 9. Treatment of 7 with tBuN(H)CH2CH2N(H)tBu in the presence of Et3N furnished the corresponding 2-cymantrenyl-diazaborolidine 15. The novel compounds were characterized by elemental analyses and various spectroscopic techniques (IR; 1H, 13C, and 11B NMR; MS). The molecular structures of 3, 6, and 15 were elucidated by X-ray diffraction analyses. Cyclovoltammetric studies of the ferrocene derivatives at high scan rates show features of a quasireversible oxidation at the iron center. The heterocyclic groups serve as electron donors, considerably lowering the oxidation potential of the central iron atoms when compared to the parent compound ferrocene. (© Wiley-VCH Verlag GmbH & Co. KGaA, 69451 Weinheim, Germany, 2005) [source] o -Amine-Assisted Cannizzaro Reaction of Glyoxal with New 2,6-DiaminoanilinesEUROPEAN JOURNAL OF ORGANIC CHEMISTRY, Issue 14 2009Yuhki Irie Abstract The preparation of several new o -amine-substituted anilines was achieved according to a new bifunctional molecular design, and their reactions with glyoxal were conducted. Cannizzaro reactions of glyoxal proceeded using specifically designed anilines, such as 2,6-dipyrrolidinyl-, 2,6-dipiperidinyl-, 2,6-dimorpholinyl-, and 2-pyrrolidinyl-aniline, which are new and can easily be synthesized by substitution of halogen-substituted nitrobenzene with amines and subsequent reduction with hydrogen, to form ,-hydroxy acetamide and ,-amino acetamide derivatives, as a result of the Cannizzaro reaction. In comparison with the reaction of glyoxal with p -pyrrolidinylaniline to form a common diimine product, the reaction with o -pyrrolidinylaniline leads only to ,-hydroxy amides, strongly suggesting that the abnormal Cannizzaro reactions are attributed to the existence of basic nitrogen atoms at the o -positions, which suppress diimine formation and assist the generation of acetamides.(© Wiley-VCH Verlag GmbH & Co. KGaA, 69451 Weinheim, Germany, 2009) [source] New Monodentate P,C-Stereogenic Bicyclic Phosphanes: 1-Phenyl-1,3a,4,5,6,6a-hexahydrocyclopenta[b]phosphole and 1-Phenyloctahydrocyclopenta[b]phospholeEUROPEAN JOURNAL OF ORGANIC CHEMISTRY, Issue 18 2004Zbigniew Pakulski Abstract Racemic1-phenyl-1,3a,4,5,6,6a-hexahydrocyclopenta[b]phosphole (4) was separated into enantiomerically pure 1-phenyl-1,3a,4,5,6,6a-hexahydrocyclopenta[b]phosphole 1-oxides [(RP)- 6 and (SP)- 6] by an oxidative resolution procedure involving treatment of 4 with menthyl bromoacetate, crystallization of the resulting diastereoisomeric phosphonium bromides 8, and stereoselective hydrolysis of the diastereomerically pure salts to the corresponding enantiomerically pure phosphane oxides. Stereoretentive reduction of P=O in (RP)- 6 gave enantiomerically pure (SP)- 4. Hydrogenation of (SP)- 6 and subsequent reduction of P=O afforded saturated 1-phenyloctahydrocyclopenta[b]phosphole [(RP)- 5]. Monophosphanes (SP)- 4 and (RP)- 5 were tested as chiral ligands and catalysts in model asymmetric hydrogenation and C,C bond-forming reactions. Enantioselectivities of up to 95% were observed. (© Wiley-VCH Verlag GmbH & Co. KGaA, 69451 Weinheim, Germany, 2004) [source] Genetically Engineered Phage Fibers and Coatings for Antibacterial ApplicationsADVANCED FUNCTIONAL MATERIALS, Issue 2 2010Joan Y. Mao Abstract Multifunctionality can be imparted to protein-based fibers and coatings via either synthetic or biological approaches. Here, potent antimicrobial functionality of genetically engineered, phage-based fibers and fiber coatings, processed at room temperature, is demonstrated. Facile genetic engineering of the M13 virus (bacteriophage) genome leverages the well-known antibacterial properties of silver ions to kill bacteria. Predominant expression of negatively charged glutamic acid (E3) peptides on the pVIII major coat proteins of M13 bacteriophage enables solution-based, electrostatic binding of silver ions and subsequent reduction to metallic silver along the virus length. Antibacterial fibers of micrometer-scale diameters are constructed from such an E3-modified phage via wet-spinning and glutaraldehyde-crosslinking of the E3-modified viruses. Silverization of the free-standing fibers is confirmed via energy dispersive spectroscopy and inductively coupled plasma atomic emission spectroscopy, showing ,0.61,µg cm,1 of silver on E3,Ag fibers. This degree of silverization is threefold greater than that attainable for the unmodified M13,Ag fibers. Conferred bactericidal functionality is determined via live,dead staining and a modified disk-diffusion (Kirby,Bauer) measure of zone of inhibition (ZoI) against Staphylococcus epidermidis and Escherichia coli bacterial strains. Live,dead staining and ZoI distance measurements indicate increased bactericidal activity in the genetically engineered, silverized phage fibers. Coating of Kevlar fibers with silverized E3 phage exhibits antibacterial effects as well, with relatively smaller ZoIs attributable to the lower degree of silver loading attainable in these coatings. Such antimicrobial functionality is amenable to rapid incorporation within fiber-based textiles to reduce risks of infection, biofilm formation, or odor-based detection, with the potential to exploit the additional electronic and thermal conductivity of fully silverized phage fibers and coatings. [source] Fine-microstructure Mediated Efficient Hydrogen Oxidation in Ni/YSZ Anode Fabricated from Novel Co-precipitation Derived NanocompositesFUEL CELLS, Issue 2 2010K. Sato Abstract Fine-microstructure mediated efficient hydrogen oxidation was demonstrated on nickel/yttria-stabilised zirconia (Ni/YSZ) anode fabricated from NiO/YSZ nanocomposite particles, synthesised via a novel co-precipitation method using YSZ nanoparticles with the average size of 3,nm. Transmission electron microscopy image revealed that nanocomposite particles calcined at 600,°C consisted of homogeneously distributed NiO and YSZ nanocrystals, approximately 5,nm large. The Ni/YSZ anode was fabricated by sintering the screen-printed nanocomposites at 1,300,°C and their subsequent reduction. The anode had a uniform porous microstructure consisting of fine grains in the range of 200,300,nm, and exhibited quite low area-specific resistance (ASR) of 2.29, 0.43 and 0.15,,,cm2 at 600, 700 and 800,°C, respectively. [source] Magnetically Anisotropic Cobalt and Iron Nanofibers via ElectrospinningADVANCED MATERIALS, Issue 23 2007M. Graeser Magnetically anisotropic cobalt and iron nanofibers (see figure) are obtained via oriented polymer-supported electrospinning and subsequent reduction and thermal treatment. The cobalt and iron nature of the fibers is confirmed by XRD analysis. Fibers of both metals show ferromagnetic behavior. Parallel aligned iron nanofibers revealed anisotropic hysteresis loops depending on field-fiber orientation. [source] A case of refractory vasculitic ulcers in a systemic lupus erythematosus patient responding to rituximab and hyperbaric oxygen therapyINTERNATIONAL JOURNAL OF RHEUMATIC DISEASES, Issue 4 2009Nai-Lee LUI Abstract Large refractory vasculitic ulcers are not commonly seen in systemic lupus erythematosus (SLE) patients. We report a case of refractory vasculitic ulcers responding to rituximab, a monoclonal antibody directed against CD20 cells leading to prolonged B cell depletion. This treatment was initiated after treatment with high-dose steroids and other immunosuppressants were ineffective/associated with significant side-effects. Following treatment with rituximab, there was sustained clinical improvement and subsequent reduction of prednisolone dose. Rituximab was well-tolerated. Concomitant methotrexate therapy and hyperbaric oxygen therapy (HBOT) may have aided the recovery of the patient's vasculitic ulcers. This case and anecdotal reports have illustrated the efficacy and safety of rituximab in the treatment of refractory SLE-related vasculitic ulcers. Further studies to determine the long-term efficacy and side-effects would be useful. [source] Novel Enantioselective Sequentially Rhodium(I)/BINAP- Catalyzed Cycloisomerization,Hydrogenation,Isomerization, Acetalization (CIHIA)ADVANCED SYNTHESIS & CATALYSIS (PREVIOUSLY: JOURNAL FUER PRAKTISCHE CHEMIE), Issue 17 2009Nadine Körber Abstract Linear, easily accessible alkyl and (hetero)aryl-substituted alkynyl allyl alcohols are readily and enantioselectively transformed into 2,7-dioxabicyclo[3.2.1]octanes by a sequential rhodium-catalyzed process. Based on the initial cycloisomerization, the in situ generated rhodium(I)-BINAP complex enables a subsequent reduction with hydrogen and the transformation into bicyclic frameworks. [source] Layered Double Hydroxide Supported Nanoplatinum and Nanopalladium Catalyzed Allylation of Aldehydes: A Mechanistic StudyADVANCED SYNTHESIS & CATALYSIS (PREVIOUSLY: JOURNAL FUER PRAKTISCHE CHEMIE), Issue 15 2005M. Choudary Abstract Layered double hydroxide (LDH)-supported nanoplatinum(0) and nanopalladium(0) catalysts were prepared by a simple ion exchange technique and subsequent reduction with hydrazine hydrate and used for the allylation of aldehydes to give moderate to good yields of homoallylic alcohols. Detailed mechanistic studies of LDH-Pd(0)-catalyzed allylation using XPS and TGA-MS reveal that a monoallyl-palladium complex is the key intermediate for the catalytic cycle. [source] Synthesis and reactions of 3-amino-2-methyl-3H -[1,2,4]triazolo[5,1- b]-quinazolin-9-one and 2-hydrazino-3-phenylamino-3H -quinazolin-4-oneJOURNAL OF HETEROCYCLIC CHEMISTRY, Issue 6 2003Mohamed A. Saleh The reaction of 3- N -(2-mercapto-4-oxo-4H -quinazolin-3-yl)acetamide (1) with hydrazine hydrate yielded 3-amino-2-methyl-3H -[1,2,4]triazolo[5,1- b]quinazolin-9-one (2). The reaction of 2 with o -chlorobenzaldehyde and 2-hydroxy-naphthaldehyde gave the corresponding 3-arylidene amino derivatives 3 and 4, respectively. Condensation of 2 with 1-nitroso-2-naphthol afforded the corresponding 3-(2-hydroxy-naphthalen-1-yl-diazenyl)-2-methyl-3H -[1,2,4]triazolo[5,1- b]quinazolin-9-one (5), which on subsequent reduction by SnCl2 and HCl gave the hydrazino derivative 6. Reaction of 2 with phenyl isothiocyanate in refluxing ethanol yielded thiourea derivative 7. Ring closure of 7 subsequently cyclized on refluxing with phencyl bromide, oxalyl dichloride and chloroacetic acid afforded the corresponding thiazolidine derivatives 8, 9 and 10, respectively. Reaction of 2-mercapto-3-phenylamino-3H -quinazolin-4-one (11) with hydrazine hydrate afforded 2-hydrazino-3-phenylamino-3H -quinazolin-4-one (12). The reactivity 12 towards carbon disulphide, acetyl acetone and ethyl acetoacetate gave 13, 14 and 15, respectively. Condensation of 12 with isatin afforded 2-[N -(2-oxo-1,2-dihydroindol-3-ylidene)hydrazino]-3-phenylamino-3H -quinazolin-4-one (16). 2-(4-Oxo-3-phenylamino-3,4-dihydroquinazolin-2-ylamino)isoindole-1,3-dione (17) was synthesized by the reaction of 12 with phthalic anhydride. All isolated products were confirmed by their ir, 1H nmr, 13C nmr and mass spectra. [source] Mass spectrometry of steroid glucuronide conjugates.JOURNAL OF MASS SPECTROMETRY (INCORP BIOLOGICAL MASS SPECTROMETRY), Issue 9 2001-diol 3-, -steroid-, -steroid-17- O -, 17-glucuronides, 3-keto-, Electron impact fragmentation of 3-keto-4-en-, glucuronides Abstract The steroid glucuronide conjugates of 16,16,17-d3 -testosterone, epitestosterone, nandrolone (19-nortestosterone), 16,16,17-d3 -nortestosterone, methyltestosterone, metenolone, mesterolone, 5,-androstane-3,,17,-diol, 2,2,3,4,4-d5 -5,-androstane-3,,17,-diol, 19-nor-5,-androstane-3,,17,-diol, 2,2,4,4-d4 -19-nor-5,-androstane-3,,17,-diol and 1,-methyl-5,-androstane-3,/,,17,-diol were synthesized by means of the Koenigs,Knorr reaction. Selective 3- or 17- O -conjugation of bis-hydroxylated steroids was performed either by glucuronidation of the corresponding steroid ketole and subsequent reduction of the keto group or via a four-step synthesis starting from a mono-hydroxylated steroid including (a) protection of the hydroxy group, (b) reduction of the keto group, (c) conjugation reaction and (d) removal of protecting groups. The mass spectra and fragmentation patterns of all glucuronide conjugates were compared with those of the commercially available testosterone glucuronide and their characterization was performed by gas chromatography/mass spectrometry and nuclear magnetic resonance spectroscopy. For mass spectrometry the substances were derivatized to methyl esters followed by trimethylsilylation of hydroxy groups and to pertrimethylsilylated products using labelled and unlabelled trimethylsilylating agents. The resulting electron ionization mass spectra obtained by GC/MS quadrupole and ion trap instruments, full scan and selected reaction monitoring experiments are discussed, common and individual fragment ions are described and their origins are proposed. Copyright © 2001 John Wiley & Sons, Ltd. [source] Bis-(3-hydroxyphenyl) diselenide inhibits LPS-stimulated iNOS and COX-2 expression in RAW 264.7 macrophage cells through the NF- kB inactivationJOURNAL OF PHARMACY AND PHARMACOLOGY: AN INTERNATI ONAL JOURNAL OF PHARMACEUTICAL SCIENCE, Issue 4 2009Kyung-Min Shin Abstract Objectives Previously, we reported that diaryl diselenide compounds have strong inhibitory effects on lipopolysaccharide (LPS)-induced nitric oxide (NO) production in macrophages. In this study, we investigated the molecular mechanisms underlying NO suppression and prostaglandin E2 (PGE2) production by diaryl diselenide compounds, bis-(2-hydroxyphenyl) diselenide (DSE-A), bis-(3-hydroxyphenyl) diselenide (DSE-B), bis-(4-hydroxyphenyl) diselenide (DSE-C), dipyridyl diselenide (DSE-D) and diphenyl diselenide (DSE-E). Methods The effect of these compounds on NO suppression and PGE2 production was investigated in RAW 264.7 macrophages. Key findings Our data indicate that of the above, DSE-B most potently inhibits NO and PGE2 production, and that it also significantly reduces the releases of tumour necrosis factor (TNF)-,, interleukin(IL)-1, and IL-6. Consistent with these observations, DSE-B also reduced the protein levels of inducible NO synthase (iNOS) and cyclooxygenase-2 (COX-2), and the mRNA levels of iNOS, COX-2, TNF-,, IL-1, and IL-6. Furthermore, DSE-B inhibited LPS-induced nuclear factor-,B (NF-,B) activation, which was associated with the prevention of the inhibitor ,B-, (I,B-,) degradation and a subsequent reduction in nuclear p65 protein levels. Conclusions Taken together, our data suggest that the anti-inflammatory properties of DSE-B are due to reduction in the expression of iNOS, COX-2, TNF-,, IL-1, and IL-6 through the down-regulation of NF-,B binding activity. [source] Synthesis of poly(vinyl ether) polyols with pendant oxyethylene chains and properties of hydrophilic, thermo-responsive polyurethanes prepared therefromJOURNAL OF POLYMER SCIENCE (IN TWO SECTIONS), Issue 7 2010Tamotsu Hashimoto Abstract Hydroxy-terminated telechelic poly(vinyl ether)s with pendant oxyethylene chains were synthesized by the reaction of the CH3CH(OCOCH3)O[CH2]4OCH(OCOCH3)CH3/Et1.5AlCl1.5/THF-based bifunctional living cationic polymers of 2-methoxyethyl vinyl ether (MOVE), 2-ethoxyethyl vinyl ether (EOVE), and 2-(2-methoxyethoxy)ethyl vinyl ether (MOEOVE) with water and the subsequent reduction of the aldehyde polymer terminals with NaBH4. The obtained poly(vinyl ether) polyols were reacted with an equimolar amount of toluene diisocyanates [a mixture of 2,4- (80%) and 2,6- (20%) isomers] to give water-soluble polyurethanes. The aqueous solutions of these polyurethanes caused thermally induced precipitation at a particular temperature depending on the sort of the thermosensitive poly(vinyl ether) segments containing oxyethylene side chains. These polyurethanes also function as polymeric surfactants, lowered the surface tension of their aqueous solutions. © 2010 Wiley Periodicals, Inc. J Polym Sci Part A: Polym Chem 48: 1641,1648, 2010 [source] Abarelix and other gonadotrophin-releasing hormone antagonists in prostate cancerBJU INTERNATIONAL, Issue 11 2009Roger S. Kirby Hormonal therapy is the main recommended treatment for locally advanced and metastatic prostate cancer. Luteinizing hormone-releasing hormone (LHRH) agonists, such as buserelin, goserelin, leuprorelin and triptorelin, stimulate the pituitary's gonadotrophin-releasing hormone (GnRH) receptor, ultimately leading to its de-sensitization and subsequent reduction of LH and testosterone levels. However, this reduction is accompanied by a well described increase or ,surge' in LH and testosterone levels, necessitating the concomitant administration of an antiandrogen to combat the potential effects of transient acceleration in cancer activity. Two pure GnRH antagonists have been developed, abarelix and degarelix, that are devoid of any agonist effect on the GnRH receptor and consequently do not result in testosterone flare. Abarelix was the first GnRH antagonist to be developed and was approved by the USA Food and Drug Administration in 2004 for the initiation of hormonal castration in advanced or metastasizing hormone-dependent prostate carcinoma, when rapid androgen suppression is necessary. Clinical data on both abarelix and degarelix show that they can produce rapid and sustained decreases in testosterone to castrate levels without the need for co-administration of an antiandrogen, and with a very low complication rate in the short term. [source] Low expression of interferon regulatory factor-1 and identification of novel exons skipping in patients with chronic myeloid leukaemiaBRITISH JOURNAL OF HAEMATOLOGY, Issue 1 2002Dimitrios Tzoanopoulos Summary. Chronic myeloid leukaemia (CML) is a malignant clonal disorder of the haematopoietic stem cell. Treatment of CML patients with interferon alpha (IFN-,) has induced haematological and cytogenetic remission. Interferons transcriptionally activate target genes through the JAK,STAT and interferon regulated factors (IRFs) family pathways. Interferon regulated factor-1 (IRF-1) is a transcriptional activator of genes critical for cell growth, differentiation and apoptosis. The skipping of exons 2 or 2 and 3 of IRF-1 in patients with myelodysplastic syndromes and acute myelogenous leukaemia suggests that this factor may have a critical role in leukaemogenesis. The role of IRF-1 in CML is currently unknown. Therefore, mutational analysis of IRF-1 was performed and its expression pattern was also studied in CML patients. We studied IRF-1 in peripheral blood mononuclear cells of 21 patients in chronic phase CML. No point mutations were identified at the cDNA level. Surprisingly, fourfold reduction of full-length IRF-1 mRNA expression was established in 17/21 patients compared with normal individuals. Low expression of full-length IRF-1 was observed in conjunction with high levels of aberrantly spliced mRNAs, reported for the first time. In three patients who were also analysed during blastic transformation, further reduction of full-length IRF-1 mRNA was observed. These findings demonstrate that, in CML patients, IRF-1 can produce high levels of aberrant spliced mRNAs with subsequent reduction in the levels of full-length IRF-1 mRNA. This observation is consistent with the notion that exon skipping may constitute another mechanism of tumour suppressor gene inactivation in this disease. [source] Effects of local delivery of trapidil on neointima formation in a rabbit angioplasty modelBRITISH JOURNAL OF PHARMACOLOGY, Issue 3 2000Kai Zacharowski Smooth muscle cell (SMC) proliferation can result in luminal reduction of a vessel following balloon angioplasty. This study was designed (i) to determine if local administration of trapidil (triazolopyrimidine) into a vessel wall reduces neointima formation, and (ii) to explore the mechanism involved in the subsequent reduction in cell proliferation. Following balloon angioplasty in 40 anaesthetized New Zealand White rabbits, trapidil (50,200 mg) or its vehicle (saline) was injected into the dilated vessel wall of the right femoral artery. Experimental groups and time of investigation: (I) vehicle (2 weeks, n=3), (II) trapidil-100 mg (2 weeks, n=3), (III) vehicle (3 weeks, n=8), (IV) trapidil-50 mg (3 weeks, n=5); (V) trapidil-100 mg (3 weeks, n=9) or (V) trapidil-200 mg (3 weeks, n=7). After 2 weeks, there was a significant reduction of intimal hyperplasia (expressed as intima to media area ratio) in the trapidil group compared with vehicle (0.44±0.04 vs 0.93±0.04, *P<0.05) and also a significant reduction in cell proliferation (% ratio of BrdU-positive cells to total cell number: vehicle 14±2% vs trapidil 6±1%, *P<0.05). After 3 weeks, there was a dose-dependent reduction of intimal hyperplasia in the trapidil groups compared with vehicle (trapidil 50 mg 1.14±0.04; trapidil 100 mg 0.91±0.09*; trapidil 200 mg 0.77±0.09* vs vehicle 1.67±0.23, *P<0.05). Thus, the local administration of trapidil to the rabbit femoral artery reduces the neointima formation, which occurs 2 or 3 weeks after balloon angioplasty via a mechanism, which is dependent on inhibition of cell proliferation. British Journal of Pharmacology (2000) 129, 566,572; doi:10.1038/sj.bjp.0703098 [source] Thrombectomy during PCI for acute myocardial infarctionCATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, Issue 7 2008Are the randomized controlled trial data relevant to the patients who really need this technique? Abstract Macro and microembolization during percutaneous coronary intervention (PCI) in ST elevation acute myocardial infarction (STEAMI) is frequent and may result in obstruction of the microvascular network with subsequent reduction in efficacy of reperfusion. Numerous mechanistic studies have shown that the presence and size of the culprit thrombus is the most powerful predictor of incidence of embolization and slow flow/no reflow. Techniques that have been used to reduce the incidence of these events include thrombectomy devices and embolic protection devices. Although numerous prospective randomized clinical trials have been performed to evaluate the role of thrombectomy devices in patients with STEAMI, the results of these trials are conflicting and they speak to both sides of the controversy. The Achilles heal of the majority of these trials is the premise that thrombectomy devices should be routinely used in all patients presenting with STEAMI even irrespective of the presence and size of the thrombus. Such a hypothesis is naively optimistic and it ignores the basic knowledge available to us regarding the relationship between thrombus burden and embolization. Nonetheless, clinicians are faced every day with the reality of making difficult decisions on how to best treat patients presenting with STEAMI and large thrombus burden. The current available "evidence-based medicine" cannot and should not be generalized to these patients because only a minority of these patients was included in these randomized clinical trials. In these patients, thrombectomy devices should be strongly considered as an integral part of the armamentarium available to reduce thrombus burden prior to definitive treatment. Whether a future clinical trial will provide a definitive answer in terms of clinical outcome difference is doubtful because such a trial will need to include large number of selected patients with STEAMI who both have large amount of myocardium at jeopardy and large thrombus burden, a difficult and possibly undoable study. © 2008 Wiley-Liss, Inc. [source] Early ostial saphenous vein graft stenosis associated with the use of Symmetry sutureless aortic proximal anastomosis device: Successful percutaneous revascularizationCATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, Issue 2 2004Sharon L. Cline MD Abstract A recent advance in technology permits the creation of sutureless proximal aortic anastomosis during coronary artery bypass graft surgery. This new tool has significant potential benefit by minimizing aortic manipulation with subsequent reduction in neuroembolization. Implantation of a nitinol-based proximal aortic connector (Symmetry) has a potential to elicit intimal hyperplastic reaction analogous to restenosis after coronary stent placement. We report cases of early vein graft stenosis in association with the use of the Symmetry device. Three patients suffered from severe ostial stenosis within 6 months of bypass surgery with symptomatic presentation. Of these three patients, two underwent successful percutaneous revascularization. Fluoroscopic star-shaped appearance of the metallic Symmetry allows device recognition during angiography. We review current data regarding graft patency with the use of Symmetry device and discuss technical issues to address specific problems during percutaneous revascularization. Catheter Cardiovasc Interv 2004;62:203,208. © 2004 Wiley-Liss, Inc. [source] The Breakdown of the Minimum Polarizability Principle in Vibrational Motions as an Indicator of the Most Aromatic CenterCHEMISTRY - A EUROPEAN JOURNAL, Issue 20 2005Miquel Torrent-Sucarrat Dr. Abstract The vibrational motions that disobey the minimum polarizability principle (MPP) in ,-conjugated molecules are distortions of the equilibrium geometry that produce a reduction in the polarizability due to the localization of , electrons. For aromatic species, this electronic localization is responsible for the subsequent reduction in the aromaticity of the system. In the present work, we diagonalize the Hessian matrix of the polarizability with respect to the vibrational nontotally symmetric normal coordinates, to calculate the nontotally symmetric distortions that produce the maximum breakdown of the MPP in a series of twenty polycyclic aromatic hydrocarbons. It is shown that the nuclear displacements that break the MPP have larger components in those rings that possess the highest local aromaticity. Thus, these vibrational motions can be used as an indicator of local aromaticity. [source] Clinical course of kidney transplant patients with acute rejection and BK virus replication following Campath therapyCLINICAL TRANSPLANTATION, Issue 3 2008Liise K. Kayler Abstract:, Background:, Kidney transplant recipients with active BK virus (BKV) replication are generally treated with reduction in immunosuppression to allow a successful immune response against the virus. Methods:, We inadvertently administered Campath to two patients with BKV viruria, and one patient with BKV nephropathy, since allograft biopsies showed severe tubulitis or intimal arteritis, and results of PCR and in situ hybridization were not available at the time of therapeutic intervention. Results:, Increased viral replication was observed, but not uniformly in all cases, and follow-up biopsies showed nephropathy in one additional case. Extra-renal dissemination did not occur. With subsequent reduction of immunosuppression or antiviral therapy, it was still possible to obtain clearance of viremia in all cases. Serum creatinine fell transiently after Campath in one patient; however, at one yr post-treatment all had increased levels over baseline. One graft was lost to persistent acute rejection that led to interstitial fibrosis and tubular atrophy. Conclusion:, These cases suggest that Campath treatment does not (i) irreversibly deplete cells believed to be important in mounting an immune response against BKV, or (ii) preclude subsequent eradication of viral DNA from the blood. [source] Mechanisms of behavior change in alcoholics anonymous: does Alcoholics Anonymous lead to better alcohol use outcomes by reducing depression symptoms?ADDICTION, Issue 4 2010John F. Kelly ABSTRACT Rationale Indices of negative affect, such as depression, have been implicated in stress-induced pathways to alcohol relapse. Empirically supported continuing care resources, such as Alcoholics Anonymous (AA), emphasize reducing negative affect to reduce relapse risk, but little research has been conducted to examine putative affective mechanisms of AA's effects. Methods Using lagged, controlled, hierarchical linear modeling and mediational analyses this study investigated whether AA participation mobilized changes in depression symptoms and whether such changes explained subsequent reductions in alcohol use. Alcohol-dependent adults (n = 1706), receiving treatment as part of a clinical trial, were assessed at intake, 3, 6, 9, 12 and 15 months. Results Findings revealed elevated levels of depression compared to the general population, which decreased during treatment and then remained stable over follow-up. Greater AA attendance was associated with better subsequent alcohol use outcomes and decreased depression. Greater depression was associated with heavier and more frequent drinking. Lagged mediation analyses revealed that the effects of AA on alcohol use was mediated partially by reductions in depression symptoms. However, this salutary effect on depression itself appeared to be explained by AA's proximal effect on reducing concurrent drinking. Conclusions AA attendance was associated both concurrently and predictively with improved alcohol outcomes. Although AA attendance was associated additionally with subsequent improvements in depression, it did not predict such improvements over and above concurrent alcohol use. AA appears to lead both to improvements in alcohol use and psychological and emotional wellbeing which, in turn, may reinforce further abstinence and recovery-related change. [source] | ||||||||||||||||